Stock Events

Nurosene Health 

C$0.43
0
+C$0+0% Tuesday 21:36

Statistics

Day High
0
Day Low
0
52W High
0.75
52W Low
0
Volume
0
Avg. Volume
37,989
Mkt Cap
20.13M
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MEND.CN. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a major player in the pharmaceutical industry, directly competing with NetraMark in drug development and personalized medicine.
Novartis
NVS
Mkt Cap232.42B
Novartis is involved in advanced pharmaceuticals and personalized healthcare solutions, overlapping with NetraMark's focus areas.
Merck &
MRK
Mkt Cap318.55B
Merck operates in the pharmaceutical sector, focusing on innovative therapies that compete with NetraMark's offerings.
Lilly(Eli) &
LLY
Mkt Cap814.94B
Eli Lilly is a leader in pharmaceuticals, particularly in areas that utilize AI for drug discovery, similar to NetraMark's approach.
GSK
GSK
Mkt Cap81.55B
GlaxoSmithKline focuses on research in pharmaceuticals, competing with NetraMark in the development of new drugs and health solutions.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie works in biopharmaceuticals, directly competing with NetraMark in therapeutic areas and personalized medicine.
AMGEN
AMGN
Mkt Cap177.72B
Amgen specializes in biotechnological medicines, which aligns with NetraMark's focus on innovative healthcare solutions.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol-Myers Squibb is a major biopharma company, competing in the same space as NetraMark with a focus on serious diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap114.81B
Regeneron Pharmaceuticals focuses on genetic and biomarker-driven drug development, similar to NetraMark's AI-driven approach.
Vertex Pharmaceuticals
VRTX
Mkt Cap126.85B
Vertex Pharmaceuticals is known for its scientific innovations in healthcare, competing with NetraMark in drug discovery and development.

About

NetraMark Holdings Inc. focuses on developing artificial intelligence and machine learning solutions for pharmaceutical and biotechnology companies in Canada. The company develops NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas, a consulting service that helps to discover new drugs, repurpose existing drugs, and resurrect drugs that have failed clinical trials, as well as Nuro app that helps athletes to deal with mental performance. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. George Achilleos
Country
CA
ISIN
CA64132U1003
WKN
000A3D5X9

Listings

F
DE
PF0.F
OTCM
US
AINMF
CN
CA
AIAI.CN
CN
CA
MEND.CN